BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 21612599)

  • 21. The psychosocial impact of an abnormal cervical smear result.
    Drolet M; Brisson M; Maunsell E; Franco EL; Coutlée F; Ferenczy A; Fisher W; Mansi JA
    Psychooncology; 2012 Oct; 21(10):1071-81. PubMed ID: 21695747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychosocial outcomes of three triage methods for the management of borderline abnormal cervical smears: an open randomised trial.
    McCaffery KJ; Irwig L; Turner R; Chan SF; Macaskill P; Lewicka M; Clarke J; Weisberg E; Barratt A
    BMJ; 2010 Feb; 340():b4491. PubMed ID: 20179125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Women's experiences with cervical cancer screening in a colposcopy referral clinic in Cape Town, South Africa: a qualitative analysis.
    Momberg M; Botha MH; Van der Merwe FH; Moodley J
    BMJ Open; 2017 Feb; 7(2):e013914. PubMed ID: 28213603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Having a Pap smear, quality of life before and after cervical screening: a questionnaire study.
    Korfage IJ; van Ballegooijen M; Wauben B; Looman CW; Habbema JD; Essink-Bot ML
    BJOG; 2012 Jul; 119(8):936-44. PubMed ID: 22568482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perceptions and concerns of women undergoing Pap smear examination in a tertiary care hospital of India.
    Tiwari A; Kishore J; Tiwari A
    Indian J Cancer; 2011; 48(4):477-82. PubMed ID: 22293264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Do follow-up recommendations for abnormal Papanicolaou smears influence patient adherence?
    Melnikow J; Chan BK; Stewart GK
    Arch Fam Med; 1999; 8(6):510-4. PubMed ID: 10575390
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Women's experiences in coping with abnormal Papanicolaou results and follow-up colposcopy.
    Lauver DR; Baggot A; Kruse K
    J Obstet Gynecol Neonatal Nurs; 1999; 28(3):283-90. PubMed ID: 10363540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient-provider communication with HIV-positive women about abnormal Pap test results.
    Wigfall LT; Bynum SA; Friedman DB; Brandt HM; Richter DL; Glover SH; Hébert JR
    Women Health; 2017 Jan; 57(1):19-39. PubMed ID: 26886433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PEAPS-Q: a questionnaire to measure the psychosocial effects of having an abnormal pap smear. Psychosocial Effects of Abnormal Pap Smears Questionnaire.
    Bennetts A; Irwig L; Oldenburg B; Simpson JM; Mock P; Boyes A; Adams K; Weisberg E; Shelley J
    J Clin Epidemiol; 1995 Oct; 48(10):1235-43. PubMed ID: 7561985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pap smear screening in an urban STD clinic. Yield of screening and predictors of abnormalities.
    Shlay JC; McGill WL; Masloboeva HA; Douglas JM
    Sex Transm Dis; 1998 Oct; 25(9):468-75. PubMed ID: 9800258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Awareness of cervical cancer prevention among patients of gynecological outpatient clinic].
    Ulman-Włodarz I; Nowosielski K; Romanik M; Pozowski J; Jurek M
    Ginekol Pol; 2011 Jan; 82(1):22-5. PubMed ID: 21473052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Health Literacy, Knowledge on Cervical Cancer and Pap Smear and Its Influence on Pre-Marital Malay Muslim Women Attitude towards Pap Smear.
    Baharum NN; Ariffin F; Isa MR; Tin ST
    Asian Pac J Cancer Prev; 2020 Jul; 21(7):2021-2028. PubMed ID: 32711428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The association between cervical inflammation and histologic evidence of HPV in PAP smears and adverse pregnancy outcome in low risk population.
    Nimrodi M; Kleitman V; Wainstock T; Gemer O; Meirovitz M; Maymon E; Benshalom-Tirosh N; Erez O
    Eur J Obstet Gynecol Reprod Biol; 2018 Jun; 225():160-165. PubMed ID: 29727786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What Australian women want and when they want it: cervical screening testing preferences, decision-making styles and information needs.
    Dieng M; Trevena L; Turner RM; Wadolowski M; McCaffery K
    Health Expect; 2013 Jun; 16(2):177-88. PubMed ID: 21726363
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and predicting factors for anxiety in thai women with abnormal cervical cytology undergoing colposcopy.
    Jerachotechueantaveechai T; Charoenkwan K; Wongpakaran N
    Asian Pac J Cancer Prev; 2015; 16(4):1427-30. PubMed ID: 25743810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psychological effects of concurrent cytology and colposcopy testing in women referred to cancer counseling outpatient clinic in Belgrade.
    Markovic-Denic L; Popovac S; Djuric O; Perisic Z; Rakic S
    J BUON; 2017; 22(1):214-223. PubMed ID: 28365957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. What are women told about Pap smears that lack endocervical cells?
    Schofield MJ; Byles JE; Sanson-Fisher R
    J Med Screen; 1995; 2(2):105-8. PubMed ID: 7497154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors associated with the intention to undergo Pap smear testing in the rural areas of Indonesia: a health belief model.
    Sumarmi S; Hsu YY; Cheng YM; Lee SH
    Reprod Health; 2021 Jun; 18(1):138. PubMed ID: 34193195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Women's concerns about abnormal Papanicolaou test results.
    Lauver D; Rubin M
    J Obstet Gynecol Neonatal Nurs; 1991; 20(2):154-9. PubMed ID: 2030453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [ASC-US Pap Smear follow-up in a French department in 2077].
    Giuria C; Guiheneuc E; Coimet F; Caillez E; Baron C
    Sante Publique; 2015; 27(5):659-67. PubMed ID: 26752032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.